Prestige Consumer Healthcare Share Holder Equity 2010-2025 | PBH
Prestige Consumer Healthcare share holder equity from 2010 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
| Prestige Consumer Healthcare Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025 | $1,835 |
| 2024 | $1,655 |
| 2023 | $1,447 |
| 2022 | $1,578 |
| 2021 | $1,358 |
| 2020 | $1,171 |
| 2019 | $1,096 |
| 2018 | $1,179 |
| 2017 | $823 |
| 2016 | $744 |
| 2015 | $628 |
| 2014 | $563 |
| 2013 | $478 |
| 2012 | $403 |
| 2011 | $362 |
| 2010 | $329 |
| 2009 | $294 |
| Prestige Consumer Healthcare Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,835 |
| 2024-12-31 | $1,788 |
| 2024-09-30 | $1,732 |
| 2024-06-30 | $1,681 |
| 2024-03-31 | $1,655 |
| 2023-12-31 | $1,601 |
| 2023-09-30 | $1,536 |
| 2023-06-30 | $1,480 |
| 2023-03-31 | $1,447 |
| 2022-12-31 | $1,687 |
| 2022-09-30 | $1,620 |
| 2022-06-30 | $1,585 |
| 2022-03-31 | $1,578 |
| 2021-12-31 | $1,518 |
| 2021-09-30 | $1,462 |
| 2021-06-30 | $1,416 |
| 2021-03-31 | $1,358 |
| 2020-12-31 | $1,323 |
| 2020-09-30 | $1,278 |
| 2020-06-30 | $1,227 |
| 2020-03-31 | $1,171 |
| 2019-12-31 | $1,156 |
| 2019-09-30 | $1,113 |
| 2019-06-30 | $1,102 |
| 2019-03-31 | $1,096 |
| 2018-12-31 | $1,233 |
| 2018-09-30 | $1,193 |
| 2018-06-30 | $1,162 |
| 2018-03-31 | $1,179 |
| 2017-12-31 | $1,217 |
| 2017-09-30 | $896 |
| 2017-06-30 | $859 |
| 2017-03-31 | $823 |
| 2016-12-31 | $800 |
| 2016-09-30 | $775 |
| 2016-06-30 | $737 |
| 2016-03-31 | $744 |
| 2015-12-31 | $721 |
| 2015-09-30 | $686 |
| 2015-06-30 | $663 |
| 2015-03-31 | $628 |
| 2014-12-31 | $609 |
| 2014-09-30 | $594 |
| 2014-06-30 | $586 |
| 2014-03-31 | $563 |
| 2013-12-31 | $544 |
| 2013-09-30 | $541 |
| 2013-06-30 | $500 |
| 2013-03-31 | $478 |
| 2012-12-31 | $457 |
| 2012-09-30 | $439 |
| 2012-06-30 | $418 |
| 2012-03-31 | $403 |
| 2011-12-31 | $402 |
| 2011-09-30 | $391 |
| 2011-06-30 | $378 |
| 2011-03-31 | $362 |
| 2010-12-31 | $355 |
| 2010-09-30 | $351 |
| 2010-06-30 | $340 |
| 2010-03-31 | $329 |
| 2009-12-31 | $325 |
| 2009-09-30 | $313 |
| 2009-06-30 | $303 |
| 2009-03-31 | $294 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $4.181B | $1.138B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.034B | 28.02 |
| Boston Scientific (BSX) | United States | $152.131B | 38.08 |
| Stryker (SYK) | United States | $146.225B | 30.58 |
| EssilorLuxottica (ESLOY) | France | $128.281B | 0.00 |
| Medtronic (MDT) | Ireland | $111.581B | 15.82 |
| Haleon (HLN) | United Kingdom | $50.069B | 28.51 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.244B | 0.00 |
| ResMed (RMD) | United States | $36.611B | 27.50 |
| GE HealthCare Technologies (GEHC) | United States | $32.762B | 15.55 |
| Agilent Technologies (A) | United States | $32.366B | 21.10 |
| Terumo (TRUMY) | Japan | $26.576B | 34.52 |
| Insulet (PODD) | United States | $22.320B | 87.61 |
| Koninklijke Philips (PHG) | Netherlands | $21.929B | 15.76 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.186B | 11.68 |
| Baxter (BAX) | United States | $15.472B | 11.55 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.270B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.449B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $5.968B | 20.77 |
| Lantheus Holdings (LNTH) | United States | $5.558B | 14.02 |
| Perrigo (PRGO) | Ireland | $3.570B | 9.05 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.382B | 15.40 |
| ICU Medical (ICUI) | United States | $3.271B | 24.12 |
| Envista Holdings (NVST) | United States | $3.166B | 26.31 |
| GN Store Nord (GNNDY) | Denmark | $2.180B | 18.06 |
| QuidelOrtho (QDEL) | United States | $2.022B | 13.91 |
| LeMaitre Vascular (LMAT) | United States | $1.884B | 42.12 |
| AtriCure (ATRC) | United States | $1.726B | 0.00 |
| Acuren (TIC) | United States | $1.272B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.217B | 12.36 |
| Green Thumb Industries (GTBIF) | United States | $1.080B | 24.29 |
| Neogen (NEOG) | United States | $1.066B | 13.64 |
| Kestra Medical Technologies (KMTS) | United States | $1.025B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.021B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.968B | 12.38 |
| InMode (INMD) | Israel | $0.906B | 9.13 |
| CeriBell (CBLL) | United States | $0.633B | 0.00 |
| Evolus (EOLS) | United States | $0.628B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.602B | 0.00 |
| Owens & Minor (OMI) | United States | $0.588B | 4.88 |
| Curaleaf Holdings (CURLF) | Canada | $0.565B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.553B | 0.00 |
| Valneva SE (VALN) | France | $0.525B | 0.00 |
| Surmodics (SRDX) | United States | $0.426B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.391B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.345B | 12.68 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.304B | 54.10 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.264B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.260B | 21.97 |
| Cresco Labs (CRLBF) | United States | $0.260B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| ZimVie (ZIMV) | United States | $0.254B | 11.54 |
| Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.238B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.210B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.202B | 0.00 |
| Biote (BTMD) | United States | $0.201B | 5.65 |
| Quanterix (QTRX) | United States | $0.200B | 0.00 |
| Brainsway (BWAY) | Israel | $0.195B | 51.55 |
| Omeros (OMER) | United States | $0.193B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.182B | 14.82 |
| Organigram Global (OGI) | Canada | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.153B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 16.72 |
| Vireo Growth (VREOF) | United States | $0.127B | 0.00 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| MacroGenics (MGNX) | United States | $0.091B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| Veru (VERU) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.087B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.084B | 0.00 |
| Agape ATP (ATPC) | $0.073B | 0.00 | |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.058B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.02 |
| Nephros (NEPH) | United States | $0.036B | 48.57 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Safety Shot (SHOT) | United States | $0.019B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |